Cat. No.: X24-09-YM731
PROTAC degrader inhibitor, PROTAC Bcl2 degrader-1, Purity ≥98%
Synonym: 2378801-85-3; BCL2 degrader C5; EX-A8728; BDBM50505358; AKOS040732555; N-[2-[6-(4-Bromophenyl)sulfanyl-1,3-dioxobenzo[de]isoquinolin-2-yl]ethyl]-N'-[2-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethoxy]ethoxy]ethyl]hexanediamide; PROTAC degrader inhibitor
- CAS Number: 2378801-85-3
- Compound CID: 139035047
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Properties
Description
PROTAC Bcl2 degrader-1 is an effective PROTAC inhibitor, that has the ability to prevent the pathway of PROTAC degrader. The molecular weight of the compound is 941.84, and its molecular formula is C45H45BrN6O10S. It targets the Bcl-2, Bcl-2 and Mcl-1.
Molecular Formula
C45H45BrN6O10S
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Identity
Confirmed by NMR/HPLC/MS.
Applications
PROTAC Bcl2 degrader-1 can be studied extensively for its potential therapeutic applications in the treatment of cl-2-dependent hematological malignancies, enhancing apoptosis in cancer cells that rely on Bcl-2 for survival.
Related Products
-
PROTAC degrader inhibitor, BETd-260, Purity ≥98%
-
PROTAC degrader inhibitor, ARV-771, Purity ≥98%
-
PROTAC degrader inhibitor, PROTAC Mcl1 degrader-1, Purity ≥98%
-
PROTAC degrader inhibitor, dMCL1-2, Purity ≥98%
-
PROTAC degrader inhibitor, ERD-308, Purity ≥98%
-
PROTAC degrader inhibitor, PROTAC ER Degrader-3, Purity ≥98%